ritodrine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| sympathomimetics | 2390 | 26652-09-5 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
An adrenergic beta-2 agonist used to control PREMATURE LABOR.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 40 | mg | O |
| 40 | mg | P |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 1 | Bocci G, Oprea TI, Benet LZ |
| EoM (Fraction excreted unchanged in urine) | 10 % | Benet LZ, Broccatelli F, Oprea TI |
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 5.97 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| BA (Bioavailability) | 30 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
| Vd (Volume of distribution) | 4.40 L/kg | Lombardo F, Berellini G, Obach RS |
| CL (Clearance) | 31 mL/min/kg | Lombardo F, Berellini G, Obach RS |
| fu (Fraction unbound in plasma) | 0.64 % | Lombardo F, Berellini G, Obach RS |
| t_half (Half-life) | 2.60 hours | Lombardo F, Berellini G, Obach RS |
| S (Water solubility) | 65 mg/mL | Bocci G, Oprea TI, Benet LZ |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Jan. 22, 1991 | FDA | HOSPIRA |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Exposure during pregnancy | 193.41 | 179.07 | 62 | 387 | 155485 | 63333088 |
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Exposure during pregnancy | 206.06 | 174.14 | 52 | 263 | 101080 | 79642993 |
| Maternal exposure during pregnancy | 185.84 | 174.14 | 51 | 264 | 136487 | 79607586 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | G02CA01 | GENITO URINARY SYSTEM AND SEX HORMONES OTHER GYNECOLOGICALS OTHER GYNECOLOGICALS Sympathomimetics, labour repressants |
| MeSH PA | D018663 | Adrenergic Agents |
| MeSH PA | D000322 | Adrenergic Agonists |
| MeSH PA | D058666 | Adrenergic beta-2 Receptor Agonists |
| MeSH PA | D000318 | Adrenergic beta-Agonists |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D012102 | Reproductive Control Agents |
| MeSH PA | D013566 | Sympathomimetics |
| MeSH PA | D015149 | Tocolytic Agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Premature labor | indication | 6383007 | |
| Chorioamnionitis | contraindication | 11612004 | |
| Gestational diabetes mellitus | contraindication | 11687002 | DOID:11714 |
| Hypovolemia | contraindication | 28560003 | |
| Dehydration | contraindication | 34095006 | |
| Hyperthyroidism | contraindication | 34486009 | DOID:7998 |
| Antepartum hemorrhage | contraindication | 34842007 | |
| Migraine | contraindication | 37796009 | DOID:6364 |
| Hypertensive disorder | contraindication | 38341003 | DOID:10763 |
| Mild pre-eclampsia | contraindication | 41114007 | |
| Conduction disorder of the heart | contraindication | 44808001 | |
| Severe pre-eclampsia | contraindication | 46764007 | |
| Pulmonary hypertension | contraindication | 70995007 | DOID:6432 |
| Eclampsia in pregnancy | contraindication | 198992004 | |
| Fetal death | contraindication | 276507005 | |
| Hypertensive urgency | contraindication | 443482000 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 10.35 | acidic |
| pKa2 | 11.01 | acidic |
| pKa3 | 8.82 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Beta-2 adrenergic receptor | GPCR | AGONIST | EC50 | 7.62 | WOMBAT-PK | CHEMBL | |||
| Beta-3 adrenergic receptor | GPCR | EC50 | 6.72 | WOMBAT-PK |
External reference:
| ID | Source |
|---|---|
| 4019928 | VUID |
| N0000148013 | NUI |
| D01263 | KEGG_DRUG |
| 4018621 | VANDF |
| 4019928 | VANDF |
| C0035661 | UMLSCUI |
| CHEBI:8872 | CHEBI |
| CHEMBL785 | ChEMBL_ID |
| CHEMBL83063 | ChEMBL_ID |
| CHEMBL1367605 | ChEMBL_ID |
| CHEMBL1201160 | ChEMBL_ID |
| DB00867 | DRUGBANK_ID |
| D012312 | MESH_DESCRIPTOR_UI |
| 33572 | PUBCHEM_CID |
| 7294 | IUPHAR_LIGAND_ID |
| 2608 | INN_ID |
| 23239-51-2 | SECONDARY_CAS_RN |
| I0Q6O6740J | UNII |
| 105470 | RXNORM |
| 1276 | MMSL |
| 1407 | MMSL |
| 5430 | MMSL |
| d00603 | MMSL |
| 001813 | NDDF |
| 004732 | NDDF |
| 372893009 | SNOMEDCT_US |
| 86257005 | SNOMEDCT_US |
| 89785009 | SNOMEDCT_US |
Pharmaceutical products:
None